GleamWall
中文EN

TMCI TREACE MEDICAL CONCEPTS, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1630627 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-7.1%
TTM net income YoY-11.3%
TTM EPS YoY-6.2%
Revenue 3-yr CAGR5.2%
Net income 3-yr CAGR—

Margins

Gross margin79.6%
Operating margin-24.4%
Net margin-27.4%
FCF margin-9.1%
EBITDA margin-21.1%

Returns

ROE-74.0%
ROA-29.7%
ROIC (approx.)-31.2%
Asset turnover1.08x

Leverage & solvency

Liabilities / assets65.6%
Debt / equity0.97x
Current ratio2.58x
Interest coverage-8.17x

Cash quality & payout

Operating cash flow / net income0.16x
Accruals ratio-25.0%
Payout ratio—
Capex / revenue4.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$212.69M$209.36M
Cost of revenue$42.94M$41.09M
Gross profit$169.75M$168.26M
R&D expense$20.28M$20.59M
SG&A expense$62.74M$55.72M
Operating income-$54.15M-$55.69M
Interest expense$5.32M$5.26M
Income tax$0$0
Net income-$59.00M-$55.74M
EBITDA-$43.53M-$47.27M
EPS (basic)-0.93-0.90
EPS (diluted)-0.93-0.90
Weighted avg. shares (diluted)63.27M62.11M
Balance sheet
Cash & equivalents$10.71M$11.35M
Short-term investments$37.66M$64.33M
Receivables$42.16M$40.80M
Inventory$36.03M$39.26M
Current assets$132.05M$161.40M
PP&E, net$29.75M$25.95M
Goodwill$12.81M$12.81M
Intangibles$7.12M$8.07M
Total assets$190.58M$217.09M
Current liabilities$30.64M$34.92M
Short-term debt$1.75M$0
Long-term debt$55.58M$53.31M
Total debt$57.33M$53.31M
Total liabilities$103.25M$104.20M
Shareholders' equity$87.33M$112.89M
Net debt$46.62M$41.96M
Cash flow statement
Operating cash flow-$15.97M-$37.17M
Capital expenditure$13.52M$11.59M
Free cash flow-$29.49M-$48.76M
Investing cash flow$13.25M$35.38M
Financing cash flow$2.08M$160,000
Depreciation & amortization$10.62M$8.42M
Stock-based compensation$33.82M$30.60M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.